ADVFN Logo
Boards:
    Quotes:
      Boards
      News
      Market Data
      Markets
      Discover
      Subscribe Login/Register Profile Icon
      S&P 500
      5,277.51
      0.80%
      US Tech 100
      18,064.80
      0.02%
      Dow Jones
      38,686.32
      1.51%
      Brent Oil
      81.295
      0.00%
      Bitcoin
      68,042.62
      0.47%
      Registration Strip Icon for default Register for Free to get streaming real-time quotes, interactive charts, live options flow, and more.
      Get Started
      1. Home
      2. Investing
      3. Stocks
      4. USA
      5. NASDAQ
      6. Alexion Pharmaceuticals Inc (ALXN)

      7. Alexion Pharmaceuticals Inc (ALXN) News

      ALXN

      Alexion Pharmaceuticals (ALXN)

      Alexion Pharmaceuticals Inc
      		Date:
      Sort by:
       Showing the most relevant articles for your search:NASDAQ:ALXN
      DateTimeSourceHeadlineSymbolCompany
      07/15/20113:54PMEdgar (US Regulatory)Statement of Changes in Beneficial Ownership (4)NASDAQ:ALXNAlexion Pharmaceuticals Inc
      07/12/20114:39PMEdgar (US Regulatory)Statement of Changes in Beneficial Ownership (4)NASDAQ:ALXNAlexion Pharmaceuticals Inc
      07/12/20114:20PMEdgar (US Regulatory)Statement of Changes in Beneficial Ownership (4)NASDAQ:ALXNAlexion Pharmaceuticals Inc
      07/12/20114:10PMEdgar (US Regulatory)Statement of Changes in Beneficial Ownership (4)NASDAQ:ALXNAlexion Pharmaceuticals Inc
      07/12/20114:00PMEdgar (US Regulatory)Statement of Changes in Beneficial Ownership (4)NASDAQ:ALXNAlexion Pharmaceuticals Inc
      07/11/20111:50PMEdgar (US Regulatory)Amended Statement of Ownership (SC 13G/A)NASDAQ:ALXNAlexion Pharmaceuticals Inc
      07/07/201110:00AMBusiness WireAlexion Pharmaceuticals to Report Second Quarter 2011 Results on Thursday, July 21, 2011NASDAQ:ALXNAlexion Pharmaceuticals Inc
      07/06/20119:30AMZacksAlexion Stands at Neutral - Analyst BlogNASDAQ:ALXNAlexion Pharmaceuticals Inc
      06/20/20115:08PMEdgar (US Regulatory)Current report filing (8-K)NASDAQ:ALXNAlexion Pharmaceuticals Inc
      06/20/20115:00AMBusiness WireAlexion Initiates Clinical Trial of Eculizumab as a Potential Treatment for Patients with STEC-HUS in Expanded Response to EH...NASDAQ:ALXNAlexion Pharmaceuticals Inc
      06/15/20114:50PMEdgar (US Regulatory)Amended Statement of Changes in Beneficial Ownership (4/A)NASDAQ:ALXNAlexion Pharmaceuticals Inc
      06/15/201111:15AMZacksAlexion Cites Positive Soliris Data - Analyst BlogNASDAQ:ALXNAlexion Pharmaceuticals Inc
      06/15/201110:00AMBusiness WireAlexion to Present at the Wells Fargo Securities Healthcare ConferenceNASDAQ:ALXNAlexion Pharmaceuticals Inc
      06/11/201112:46PMBusiness WireResearchers Present Final Data from Phase 2 Studies of Soliris® (eculizumab) in Patients with aHUSNASDAQ:ALXNAlexion Pharmaceuticals Inc
      06/11/201112:45PMBusiness WireNew Data Show Renal Impairment Is Strong Predictor of Early Death in Patients with PNHNASDAQ:ALXNAlexion Pharmaceuticals Inc
      06/07/201110:00AMBusiness WireAlexion to Present at the 31st Annual William Blair & Company Growth Stock ConferenceNASDAQ:ALXNAlexion Pharmaceuticals Inc
      06/06/20119:31AMPR Newswire (US)Seven Summits Research Releases Comments on Morgan Stanley, Ciena, Alexion, Navistar and Men's WearhouseNASDAQ:ALXNAlexion Pharmaceuticals Inc
      06/03/20118:30AMZacksSpeedy Review for ALXN's Soliris - Analyst BlogNASDAQ:ALXNAlexion Pharmaceuticals Inc
      06/01/20114:05PMEdgar (US Regulatory)Statement of Changes in Beneficial Ownership (4)NASDAQ:ALXNAlexion Pharmaceuticals Inc
      06/01/20116:30AMBusiness WireFDA Grants Priority Review for Alexion’s sBLA for Soliris® (eculizumab) as a Treatment for Patients with Atypical Hemolyti...NASDAQ:ALXNAlexion Pharmaceuticals Inc
      05/31/201110:00AMBusiness WireAlexion to Present at the Goldman Sachs 32nd Annual Global Healthcare ConferenceNASDAQ:ALXNAlexion Pharmaceuticals Inc
      05/31/20119:10AMEdgar (US Regulatory)Current report filing (8-K)NASDAQ:ALXNAlexion Pharmaceuticals Inc
      05/23/201111:49AMBusiness WireResearchers to Present Nine Studies on Soliris® (eculizumab) in Patients with PNH and aHUS at EHA CongressNASDAQ:ALXNAlexion Pharmaceuticals Inc
      05/13/20115:01PMEdgar (US Regulatory)Statement of Changes in Beneficial Ownership (4)NASDAQ:ALXNAlexion Pharmaceuticals Inc
      05/13/20114:56PMEdgar (US Regulatory)Statement of Changes in Beneficial Ownership (4)NASDAQ:ALXNAlexion Pharmaceuticals Inc
      05/13/20114:52PMEdgar (US Regulatory)Statement of Changes in Beneficial Ownership (4)NASDAQ:ALXNAlexion Pharmaceuticals Inc
      05/13/20114:45PMEdgar (US Regulatory)Statement of Changes in Beneficial Ownership (4)NASDAQ:ALXNAlexion Pharmaceuticals Inc
      05/13/20114:39PMEdgar (US Regulatory)Statement of Changes in Beneficial Ownership (4)NASDAQ:ALXNAlexion Pharmaceuticals Inc
      05/13/20114:34PMEdgar (US Regulatory)Statement of Changes in Beneficial Ownership (4)NASDAQ:ALXNAlexion Pharmaceuticals Inc
      05/13/20114:26PMEdgar (US Regulatory)Statement of Changes in Beneficial Ownership (4)NASDAQ:ALXNAlexion Pharmaceuticals Inc
       Showing the most relevant articles for your search:NASDAQ:ALXN